about
Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.The contribution of PET/CT to improved patient management.Positron emission tomographic scans in lymphoma: convention and controversy.Cross-sectional imaging of nodal metastases in the abdomen and pelvis.Overview of early response assessment in lymphoma with FDG-PET.The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.Role and cost effectiveness of PET/CT in management of patients with cancer.Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma
P2860
Q33387014-D4421F6A-FADB-4BF4-AFC4-7B3376A0F090Q36371912-63EEDAD5-D0B0-45F5-AFEA-10303F7D8A6BQ36399538-31BA0D39-5C7A-4D01-9F65-0376FB4B47C0Q36560532-6C3EB5BC-71E8-4760-AB12-86D4C02D5021Q36927213-D0A14F65-8FD7-4E75-9F7A-D80D51CD73FBQ37737670-279BE4DE-5F82-4DB2-8341-41BB64DBF899Q37768682-0C65C747-86DD-4133-9655-0C94DE4D385DQ46531267-5A73CF03-378C-4904-A1BA-6D7C92BBA6ECQ46642659-5E5FD249-0248-49BE-911A-887C7CD2C28AQ46726584-A8D73165-38F8-459E-BE82-8648F1CA666EQ53536405-2EE34EC2-61FC-4ACC-BB59-1B737F386176Q57661618-AEB586E8-5688-4060-8DBE-0EF71FF3716C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
FDG-PET in the clinical management of Hodgkin lymphoma.
@ast
FDG-PET in the clinical management of Hodgkin lymphoma.
@en
type
label
FDG-PET in the clinical management of Hodgkin lymphoma.
@ast
FDG-PET in the clinical management of Hodgkin lymphoma.
@en
prefLabel
FDG-PET in the clinical management of Hodgkin lymphoma.
@ast
FDG-PET in the clinical management of Hodgkin lymphoma.
@en
P1476
FDG-PET in the clinical management of Hodgkin lymphoma
@en
P2093
Annika I Eigtved
P356
10.1016/J.CRITREVONC.2004.05.007
P577
2004-10-01T00:00:00Z